These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1201 related items for PubMed ID: 24680364

  • 1. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A, Tsur A, Haas J, Yerushalmi GM, Hourvitz A, Machtinger R, Orvieto R.
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [Abstract] [Full Text] [Related]

  • 2. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [Abstract] [Full Text] [Related]

  • 3. Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF.
    Orvieto R, Kirshenbaum M, Galiano V, Elkan-Miller T, Zilberberg E, Haas J, Nahum R.
    Front Endocrinol (Lausanne); 2020 Nov; 11():182. PubMed ID: 32528403
    [Abstract] [Full Text] [Related]

  • 4. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG, Sfontouris IA, Venetis CA, Lainas GT, Zorzovilis IZ, Tarlatzis BC, Kolibianakis EM.
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [Abstract] [Full Text] [Related]

  • 5. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J, Antaki R, Kadoch IJ, Dean NL, Sylvestre C, Bissonnette F, Benoit J, Ménard S, Lapensée L.
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [Abstract] [Full Text] [Related]

  • 6. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
    Huber M, Hadziosmanovic N, Berglund L, Holte J.
    Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
    Mohsen IA, El Din RE.
    Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
    [Abstract] [Full Text] [Related]

  • 9. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred.
    Gleicher N, Vega MV, Darmon SK, Weghofer A, Wu YG, Wang Q, Zhang L, Albertini DF, Barad DH, Kushnir VA.
    Fertil Steril; 2015 Dec; 104(6):1435-41. PubMed ID: 26348275
    [Abstract] [Full Text] [Related]

  • 10. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N, Chen Q, Hong Q, Cai R, Gao H, Wang Y, Sun L, Zhang S, Guo H, Fu Y, Ai A, Tian H, Lyu Q, Daya S, Kuang Y.
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [Abstract] [Full Text] [Related]

  • 11. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K.
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [Abstract] [Full Text] [Related]

  • 12. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization.
    Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, Aragona C.
    Fertil Steril; 2004 Jun; 81(6):1542-7. PubMed ID: 15193474
    [Abstract] [Full Text] [Related]

  • 13. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX, Zhang T, Shu L, Huang J, Diao FY, Ding W, Gao Y, Wang W, Mao YD, Cui YG, Liu JY.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar 25; 53(3):160-166. PubMed ID: 29609229
    [Abstract] [Full Text] [Related]

  • 14. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP, Nelson SM, Stoop D, Nwoye M, Humaidan P, Anckaert E, Devroey P, Tournaye H.
    Fertil Steril; 2013 Aug 25; 100(2):438-44. PubMed ID: 23602319
    [Abstract] [Full Text] [Related]

  • 15. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, Camus M, Devroey P, Tournaye H.
    Hum Reprod; 2012 Dec 25; 27(12):3481-6. PubMed ID: 22940767
    [Abstract] [Full Text] [Related]

  • 16. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
    Farhi J, Ben-Haroush A, Lande Y, Sapir O, Pinkas H, Fisch B.
    Fertil Steril; 2009 Feb 25; 91(2):377-82. PubMed ID: 18321490
    [Abstract] [Full Text] [Related]

  • 17. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R, Kruchkovich J, Rabinson J, Zohav E, Anteby EY, Meltcer S.
    Fertil Steril; 2008 Jul 25; 90(1):228-30. PubMed ID: 17681292
    [Abstract] [Full Text] [Related]

  • 18. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK, Schultze-Mosgau A, Cordes T, Diedrich K, Griesinger G.
    Arch Gynecol Obstet; 2013 Oct 25; 288(4):901-4. PubMed ID: 23545834
    [Abstract] [Full Text] [Related]

  • 19. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP.
    Hum Reprod; 2016 Feb 25; 31(2):370-6. PubMed ID: 26724797
    [Abstract] [Full Text] [Related]

  • 20. Conventional IVF as a laboratory strategy to rescue fertility potential in severe poor responder patients: the impact of reproductive aging.
    Artini PG, Obino ME, Carletti E, Pinelli S, Ruggiero M, Di Emidio G, Cela V, Tatone C.
    Gynecol Endocrinol; 2013 Nov 25; 29(11):997-1001. PubMed ID: 23909592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.